• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.
    All News #Library
    Others

    Acumen Pharma Extends Alzheimer’s Collaboration with Lonza

    CONTRACT PHARMA

    Lonza, Acumen Pharmaceuticals Ink Alzheimer’s Alliance

    GLOBENEWSWIRE

    Vaxcyte & Lonza Expand Collaboration for PCVs Vaccine

    GLOBENEWSWIRE

    Triumvira Doses 1st Patient with TAC-T Cell Therapy Using Lonza Cocoon Platform

    BUSINESSWIRE

    Production ramp-ups approved by EU; mRNA boom spurs Lonza`s Chinese expansion

    ENDPTS

    Lonza invests in new production line in China

    REUTERS

    Lonza, Sheba Medical Center Leverage Cocoon Platform for Cell Therapy

    CONTRACT PHARMA

    Lonza Extends Large-Scale MAb Commercial Supply Pact

    CONTRACT PHARMA

    Lonza, CN Bio Partner on Prevalidated Hepatocytes for Organ-on-a-chip Range

    CONTRACT PHARMA

    Lonza Invests in Facility in China

    GEN

    CellPoint and Lonza Enter Strategic Collaboration

    PRNEWSWIRE

    Lonza offloads specialty ingredients unit in $4.7B sale to Bain Capital, Cinven

    ENDPTS

    Lonza Expands Development, Mfg. Capabilities at Bend Site

    CONTRACTPHARMA

    Lonza and Be The Match BioTherapies Enter CGT Partnership

    CONTRACTPHARMA

    Lonza to Manufacture AstraZeneca`s COVID-19 Long-Acting Antibody

    CONTRACTPHARMA

    Lonza to make COVID-19 antibody combination for AstraZeneca

    REUTERS

    Lonza says first lymphoma patient dosed with CAR-T made in `Cocoon` system

    REUTERS

    Indapta, Lonza Form Immuno-oncology Partnership

    CONTRACT PHARMA

    Lonza allies with Emerald Health on synthetic cannabinoid therapy

    MANUFACTURING CHEMIST

    Lonza building biologics facility in China as country eases regulations

    FIERCE PHARMA

    Denali & Lonza Pharma & Biotech Announce Exclusive Partnership

    GLOBENEWSWIRE

    Active Pharmaceutical Ingredient Maker Lonza Biologics (LONN.VX)

    BIOSPACE

    Lonza: industry should shift to QC automation

    IN-PHARMA TECHNOLOGIST

    UK Biotech Consortium Wins £6.2m AMSCI Grant

    PHARMATIMES

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.